Skip to main content

Nasser Altorki

Dr Nasser Altorki is the Vice Chairman of Cardiothoracic Surgery and the Chief of the Division of Thoracic Surgery at the New York-Presbyterian Hospital and is the David B Skinner Professor of Cardiothoracic Surgery at Weill Cornell Medical College. He is also leader of the Experimental Therapeutics Program at the Sandra and Edward Meyer Cancer Center and Director of the Neuberger Berman Lung Cancer Research Center.

Beyond his expertise in the surgical treatment of lung cancer and other chest malignancies, he has a longstanding interest in studying the immune landscape as well as immunotherapy for early-stage lung cancer and has led several trials of adjuvant and neoadjuvant immunotherapy in early-stage lung cancer. Dr Altorki has served as the principal investigator on a number of national and international clinical trials and has written numerous manuscripts and book chapters on lung cancer screening, staging, and management of early lung cancer.


Latest contributions from Nasser Altorki

Nasser Altorki, Heather Wakelee

13-04-2022 | Non-small-cell lung cancer | Video

PD-L1 expression in early NSCLC: Interpreting the data so far

Heather Wakelee and Nasser Altorki discuss the current position on PD-L1 expression and immune checkpoint inhibition in early-stage, resectable NSCLC.